MA-STILLA-TECHNOLOGIES
Stilla Technologies Expands EMEA Footprint with New Distribution Partnerships
Stilla Technologies , the multiplex digital PCR company, today announced it has entered into agreements with 12 distributors throughout EMEA: LABGENE Scientific (Switzerland), CARLO ERBA Reagents (Italy), Bonsai Lab (Portugal and Spain), SEM (Turkey), Explorea (Czech Republic, Slovakia, Hungary), Biodynamics (Greece), AH diagnostics (Sweden, Norway, Finland, Denmark, Baltic countries), Alliance Global (Gulf, Levant, African Continent including South Africa, Central Asia, Pakistan), Danyel Biotech (Israel), Zahrawi Group (Bahrain), TK Biotech (Poland), and RIDACOM (Bulgaria). The agreements grant distribution rights to Stilla’s full product portfolio including the six-color naica® system – Stilla’s next generation multiplexing digital PCR platform – as well as microfluidic chips and reagents optimized for a wide variety of applications including cancer and liquid biopsy studies, cell and gene therapies, and infectious disease detection.
“With the expanded global availability of our powerful digital PCR solution, Stilla is answering scientists’ demand for faster turnaround time, higher precision and sensitivity,” said Matthew Grow, PhD, Vice President Global Marketing and Commercial Operations, Stilla Technologies. “We are excited to partner with leading distributors who bring deep relationships and a proven history of delivering the most innovative solutions to biomedical researchers and clinicians in their respective territories.”
With U.S. headquarters in Boston, MA, and European headquarters in Paris, France, Stilla’s expanded global distribution comes on the heels of the global launch of its six-color naica® system.
About Stilla Technologies
Stilla Technologies is the multiplex digital PCR company transforming complex genomic data into actionable insights across a wide range of research and clinical applications including cancer and liquid biopsy studies, cell and gene therapies, infectious disease detection, and food and environmental testing. Stilla’s groundbreaking Crystal Digital PCR™ solution, the naica® system , is the industry’s first digital PCR system featuring six fluorescent channels, providing biomedical researchers and clinicians the highest multiplexing and detection capacity available on the market. Stilla has U.S. headquarters in Boston, MA, European headquarters in Paris, France, and strategic distribution and business partnerships in China and throughout EMEA. To learn more, visit www.stillatechnologies.com and connect with Stilla on Twitter , LinkedIn and YouTube .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220322005193/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
TX-DENTALMONITORING18.5.2022 22:12:08 CEST | Press release
Dental Monitoring Launches the Virtual Practice Platform for a Comprehensive, Life-Long Patient Experience
ALIGN18.5.2022 17:13:06 CEST | Press release
Align Announces Additional Leadership for UK and EMEA to Support Continued Growth
CA-RMS18.5.2022 16:32:04 CEST | Press release
RMS Advances Climate Risk Modeling and Moves More Models to High Definition
MA-VERTEX-PHARMACEUTICAL18.5.2022 16:32:04 CEST | Press release
Suketu Upadhyay Elected to Vertex Board of Directors
TECNOTREE18.5.2022 16:21:11 CEST | Press release
Tecnotree Awarded as 'Change-maker of the year' by the Helsinki Stock Exchange Foundation
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom